Muhammad Zohaib Khan, “FREQUENCY OF END OF TREATMENT RESPONSE IN GENOTYPE 3 CIRRHOTIC PATIENTS TAKING SOFOSBUVIR, RIBAVIRIN AND DACLATASVIR”, J Popl Ther Clin Pharmacol, vol. 31, no. 9, pp. 4104–4128, Sep. 2024, doi: 10.53555/vgped651.